19 April 2015

Ceva to focus on science of Vaccinology during Budapest Poultry Summit >

Libourne 20th April 2015 - On April 28 - 30 in Budapest, Hungary, Ceva will hold its yearly summit designed to help poultry producers improve performance by increasing their awareness of the most innovative and integrated healthcare strategies

4 March 2015

Ceva posts strong double-digit growth again in 2014 >

Consolidated sales of the Ceva Group reached €766m at the end of 2014, representing growth of 23% and +14.1% at a constant perimeter and exchange rates.

3 March 2015

Ceva “State of the Art” Summit at VIV Asia 2015 >

Ceva’s poultry, swine, services & equipment teams will focus on what is “State of the Art” in animal production during the VIV Asia international trade show to be held in Bangkok from March 11th - 13th 2015.

11 February 2015

Discover our newly redesigned website ceva.com ! >

To better meet your expectations, and improve user experience, our website has been completely revamped !

15 January 2015

Happy new year 2015 ! >

Ceva Santé Animale wishes you all the best for 2015 !

6 January 2015

Tildren® receives FDA approval to control clinical signs of Navicular Syndrome >

Tildren® is now available in the US

1 December 2014

Ceva US Joins Fear Free™ Initiative As Inaugural Industry Sponsor >

Ceva today announced its commitment to Fear Free,™ an innovative initiative developed by “America’s Veterinarian” Dr. Marty Becker to in his words, “take the pet out of petrified and get pets back into practices.” The multi-year agreement aligns with Ceva’s leadership role and expertise in the area of pet behavior.

30 November 2014

Egypt study confirms that a single rHVT-H5 hatchery vaccination could be an effective tool to address A/H5N1 prevention >

Research confirms that in endemic countries the classical inactivated vaccines are less effective and hard to administer, while application of a rHVT vector hatchery vaccine is labour saving, cost effective and provides clinical protection against various types of H5N1 Highly Pathogenic Avian Influenza Virus after a single dose.

2 October 2014

Ceva Santé Animale reinforces its pharmaceutical production capacity, opening a new plant at its headquarters in Libourne France >

Libourne, 3 October 2014 – Ceva Santé Animale, the global veterinary health group, has invested €18 million in renovating and extending its sterile products plant in Libourne. The new industrial facility was inaugurated on 3 October and will increase injectable drug production capacity.

3 September 2014

Ceva merges all R&D activity and nominates Dr. Steve Chu as member of the Executive Committee >

Libourne 4th September 2014 - Ceva Santé Animale announced the appointment of Dr.Chu to its executive committee with responsibility for all R&D activities. The move recognises the growing importance of biotechnology and the resulting convergence of pharmaceutical and biological research. Dr.Chu joined Ceva in 2011 and has an outstanding record throughout his 30 year career in veterinary research,...